GB1441359A - N-3-alkanoyl-4-3-amino-2-hydroxy- propoxyphenyl- ureas methods for their preparation and compositions containing them - Google Patents
N-3-alkanoyl-4-3-amino-2-hydroxy- propoxyphenyl- ureas methods for their preparation and compositions containing themInfo
- Publication number
- GB1441359A GB1441359A GB5432674A GB5432674A GB1441359A GB 1441359 A GB1441359 A GB 1441359A GB 5432674 A GB5432674 A GB 5432674A GB 5432674 A GB5432674 A GB 5432674A GB 1441359 A GB1441359 A GB 1441359A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkyl
- hydrogen
- phenyl
- ureas
- alkanoyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 235000013877 carbamide Nutrition 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 1
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 125000001246 bromo group Chemical group Br* 0.000 abstract 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 abstract 1
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002346 iodo group Chemical group I* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/38—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by doubly-bound oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT1066673A AT334385B (de) | 1973-12-20 | 1973-12-20 | Verfahren zur herstellung von neuen phenoxypropylaminderivaten und deren salzen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1441359A true GB1441359A (en) | 1976-06-30 |
Family
ID=3623884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB5432674A Expired GB1441359A (en) | 1973-12-20 | 1974-12-16 | N-3-alkanoyl-4-3-amino-2-hydroxy- propoxyphenyl- ureas methods for their preparation and compositions containing them |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4034009A (enExample) |
| JP (2) | JPS5412461B2 (enExample) |
| AT (1) | AT334385B (enExample) |
| BE (1) | BE823411A (enExample) |
| CA (1) | CA1001626A (enExample) |
| CH (1) | CH612417A5 (enExample) |
| CS (1) | CS185669B2 (enExample) |
| DD (1) | DD118421A1 (enExample) |
| ES (1) | ES433145A1 (enExample) |
| FR (1) | FR2255058B1 (enExample) |
| GB (1) | GB1441359A (enExample) |
| IE (1) | IE40310B1 (enExample) |
| IL (1) | IL46259A (enExample) |
| LU (2) | LU71514A1 (enExample) |
| PL (1) | PL94095B1 (enExample) |
| RO (1) | RO69147A (enExample) |
| SU (1) | SU547174A3 (enExample) |
| YU (1) | YU36492B (enExample) |
| ZA (1) | ZA748067B (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4177280A (en) * | 1978-07-03 | 1979-12-04 | Syntex (U.S.A.) Inc. | Bicyclo[3.1.0]hexyl-substituted carbonylaminophenoxy cardiovascular agents |
| JPS5757231U (enExample) * | 1980-09-19 | 1982-04-03 | ||
| US4470965A (en) * | 1982-10-27 | 1984-09-11 | Usv Pharmaceutical Corporation | Celiprolol for the treatment of glaucoma |
| DE3410380A1 (de) * | 1984-03-21 | 1985-10-10 | Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München | S(-)-celiprolol, dessen pharmazeutisch vertraegliche salze, verfahren zu dessen herstellung, verwendung in der therapie und pharmazeutische zubereitungen |
| DE3544172A1 (de) * | 1985-12-13 | 1987-06-19 | Lentia Gmbh | Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung |
| DE3636209A1 (de) * | 1986-10-24 | 1988-04-28 | Lentia Gmbh | Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates |
| RS20050106A (sr) | 2002-08-19 | 2007-11-15 | Pfizer Products Inc., | Kombinovana terapija hiperproliferativnih bolesti |
| BRPI0410840A (pt) * | 2003-05-30 | 2006-07-04 | Ranbaxy Lab Ltd | derivados substituìdos de pirrol, composição farmacêutica contendo os mesmos e processo para sua preparação |
| GT200600381A (es) | 2005-08-25 | 2007-03-28 | Compuestos organicos | |
| WO2007029155A2 (en) * | 2005-09-05 | 2007-03-15 | Ranbaxy Laboratories Limited | An improved process for preparation of pure celiprolol base |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| JP2009514851A (ja) * | 2005-11-08 | 2009-04-09 | ランバクシー ラボラトリーズ リミテッド | （３ｒ，５ｒ）−７−［２−（４−フルオロフェニル）−５−イソプロピル−３−フェニル−４−［（４−ヒドロキシメチルフェニルアミノ）カルボニル］−ピロール−１−イル］−３，５−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法 |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| AR059838A1 (es) * | 2006-03-14 | 2008-04-30 | Ranbaxy Lab Ltd | Formulaciones para dosis estabilizantes de estatina |
| MX2009000439A (es) * | 2006-07-14 | 2009-02-04 | Ranbaxy Lab Ltd | Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas. |
| ATE547394T1 (de) | 2006-12-01 | 2012-03-15 | Bristol Myers Squibb Co | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| JP5546451B2 (ja) | 2007-06-04 | 2014-07-09 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸の障害、炎症、癌および他の障害の処置に有用なグアニル酸シクラーゼのアゴニスト |
| EP2050441A1 (en) * | 2007-10-19 | 2009-04-22 | Université Victor Segalen Bordeaux 2 | Use of beta blocker for the manufacture of a medicament for the treatment of hemangiomas |
| US8987262B2 (en) | 2007-10-19 | 2015-03-24 | Universite de Bordeaux | Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas |
| EP3241839B1 (en) | 2008-07-16 | 2019-09-04 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| HK1220696A1 (zh) | 2013-03-15 | 2017-05-12 | Bausch Health Ireland Limited | 鸟苷酸环化酶激动剂及其用途 |
| AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
| MX2015014666A (es) | 2013-04-17 | 2016-03-01 | Pfizer | Derivados de n-piperidin-3-ilbenzamida para tratar enfermedades cardiovasculares. |
| EP4424697A3 (en) | 2013-06-05 | 2024-12-25 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| DK3911648T3 (da) | 2019-01-18 | 2025-01-13 | Astrazeneca Ab | 6'-[[(1s,3s)-3-[[5-(difluormethoxy)-2-pyrimidinyl]amino]cyclopentyl]amino][1(2h),3'-bipyridin]-2-on som pcsk9-hæmmer og fremgangsmåder til anvendelse deraf |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1214012A (en) * | 1967-12-21 | 1970-11-25 | Allen & Hanburys Ltd | Phenylethanolamines |
| AT292671B (de) * | 1967-12-22 | 1971-09-10 | May & Baker Ltd | Verfahren zur Herstellung von neuen 3-(4'-Alkanoylamino-2'-acylphenoxy)-2-hydroxy-1-aminopropanen |
| US3935259A (en) * | 1970-01-08 | 1976-01-27 | Ciba-Geigy Corporation | New amines and processes for their manufacture |
| SE354851B (enExample) * | 1970-02-18 | 1973-03-26 | Haessle Ab | |
| NL7115581A (enExample) * | 1970-11-13 | 1972-05-16 | Dresden Arzneimittel | |
| GB1396322A (en) * | 1971-06-15 | 1975-06-04 | Ici Ltd | Alkanolamine derivatives |
| GB1393675A (en) | 1971-06-16 | 1975-05-07 | Ici Ltd | Alkanolamine derivatives |
| SE386892B (sv) * | 1972-07-06 | 1976-08-23 | Haessle Ab | Forfarande for framstellning av oxaminoforeningar |
| GB1455116A (en) * | 1972-12-15 | 1976-11-10 | Ici Ltd | Pharmaceutical compositions |
| AT330150B (de) * | 1973-02-28 | 1976-06-10 | Boehringer Sohn Ingelheim | Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- propargylaminopropanen und von deren saureadditionssalzen |
| GB1460593A (en) * | 1973-06-22 | 1977-01-06 | Ici Ltd | Ethanolamine derivatives |
| FI65987C (fi) * | 1973-12-12 | 1984-08-10 | Ici Ltd | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara alkanolaminderivat |
| AT334386B (de) * | 1973-12-21 | 1976-01-10 | Chemie Linz Ag | Verfahren zur herstellung von neuen phenoxypropylaminderivaten und deren salzen |
-
1973
- 1973-12-20 AT AT1066673A patent/AT334385B/de active
-
1974
- 1974-12-05 CH CH1617574A patent/CH612417A5/xx not_active IP Right Cessation
- 1974-12-11 YU YU03277/74A patent/YU36492B/xx unknown
- 1974-12-16 IE IE2585/74A patent/IE40310B1/en not_active IP Right Cessation
- 1974-12-16 BE BE151557A patent/BE823411A/xx active Protection Beyond IP Right Term
- 1974-12-16 GB GB5432674A patent/GB1441359A/en not_active Expired
- 1974-12-16 IL IL46259A patent/IL46259A/xx unknown
- 1974-12-17 CA CA216,299A patent/CA1001626A/en not_active Expired
- 1974-12-17 US US05/533,688 patent/US4034009A/en not_active Expired - Lifetime
- 1974-12-18 LU LU71514A patent/LU71514A1/xx unknown
- 1974-12-18 DD DD183145A patent/DD118421A1/xx unknown
- 1974-12-18 ZA ZA00748067A patent/ZA748067B/xx unknown
- 1974-12-19 PL PL1974176602A patent/PL94095B1/pl unknown
- 1974-12-19 FR FR7442008A patent/FR2255058B1/fr not_active Expired
- 1974-12-19 ES ES433145A patent/ES433145A1/es not_active Expired
- 1974-12-20 RO RO7480894A patent/RO69147A/ro unknown
- 1974-12-20 CS CS7400008838A patent/CS185669B2/cs unknown
- 1974-12-20 SU SU2086133A patent/SU547174A3/ru active
- 1974-12-20 JP JP14586074A patent/JPS5412461B2/ja not_active Expired
-
1978
- 1978-04-06 JP JP3982678A patent/JPS53149947A/ja active Granted
-
1993
- 1993-06-09 LU LU88296C patent/LU88296I2/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATA1066673A (de) | 1976-05-15 |
| YU327774A (en) | 1982-02-25 |
| JPS5549071B2 (enExample) | 1980-12-10 |
| ES433145A1 (es) | 1976-11-16 |
| IL46259A0 (en) | 1975-03-13 |
| IE40310B1 (en) | 1979-04-25 |
| JPS53149947A (en) | 1978-12-27 |
| CA1001626A (en) | 1976-12-14 |
| JPS5095246A (enExample) | 1975-07-29 |
| RO69147A (ro) | 1981-07-30 |
| CH612417A5 (enExample) | 1979-07-31 |
| SU547174A3 (ru) | 1977-02-15 |
| YU36492B (en) | 1984-02-29 |
| US4034009A (en) | 1977-07-05 |
| LU71514A1 (enExample) | 1975-08-20 |
| CS185669B2 (en) | 1978-10-31 |
| LU88296I2 (fr) | 1994-05-04 |
| IL46259A (en) | 1978-04-30 |
| FR2255058A1 (enExample) | 1975-07-18 |
| JPS5412461B2 (enExample) | 1979-05-23 |
| IE40310L (en) | 1975-06-20 |
| ZA748067B (en) | 1976-01-28 |
| AT334385B (de) | 1976-01-10 |
| AU7653874A (en) | 1976-06-17 |
| PL94095B1 (enExample) | 1977-07-30 |
| FR2255058B1 (enExample) | 1978-07-28 |
| DD118421A1 (enExample) | 1976-03-05 |
| BE823411A (fr) | 1975-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1441359A (en) | N-3-alkanoyl-4-3-amino-2-hydroxy- propoxyphenyl- ureas methods for their preparation and compositions containing them | |
| GB1497044A (en) | Salts of phenyl-alkanoic acids | |
| IL108697A (en) | Substituted benzoylguanidines process for their preparation and pharmaceutical compositions containing them | |
| GB1492485A (en) | Benzylamine derivatives and process for preparing them | |
| GB1399015A (en) | Fluoroalkylated phenylethylamine derivatives | |
| GB1459065A (en) | Therapeutic thiophene derivatives | |
| GB1318645A (en) | 1,2,4-triazines | |
| GB1410755A (en) | Tricyclic substituted aminoalcohols and the preparation thereof | |
| GB1308028A (en) | Thiazolylbenzoic acid derivatives and a process for their manufactur | |
| GB1436307A (en) | Diaromatic o-aminoalkyl-oximes | |
| GB1491840A (en) | Derivatives of copolymers of carbon monoxide and ethylene | |
| GB1409648A (en) | Substituted pyrrolidinemethanol compounds and pharmaceutical compositions thereof | |
| GB1435476A (en) | Thiazole derivatives processes for their preparation and compositions incorporating them | |
| GB1337371A (en) | 3-amino-imidazo-1,5-a- pyridines processes for their preparation and pharmaceutical compositions incorporating them | |
| GB1490287A (en) | Plaster composition | |
| GB1421714A (en) | Tricyclic arylalkylene lactimimides | |
| GB1449586A (en) | Naphthoylamino alkyl phenoxy-alkyl-carboxylic acid derivatives | |
| GB1398638A (en) | Furan 2-or 3-carboxylic and amides compositions thereof and methods for using same | |
| GB1452411A (en) | N,n-disubstituted benzamidines and toluamidines methods for their preparation and compositions containing them | |
| GB1444492A (en) | Butyramides their preparation and pharmaceutical compositions containing them | |
| GB1458217A (en) | Distributed azabicycloalkanes a process for their preparation and pharmaceutical compositions containing them | |
| GB1449078A (en) | Phenoxyethylamine derivatives | |
| GB1478918A (en) | N-(3-('-hydroxyimino)alkyl-*-(3 amino-2 hydroxy)-propoxy-phenyl)-ureas methods for their preparation and compositions containing them | |
| GB1316361A (en) | 5h-dibenzazepines | |
| GB1458029A (en) | Sulphamylbenzoic acids and preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| 732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
| 704A | Declaration that licence is not available as of right for an excepted use (par. 4a/1977) | ||
| CTFF | Supplementary protection certificate filed |
Free format text: SPC/GB93/051, 930602 |
|
| CTFA | Application for supplementary protection certificate granted |
Free format text: SPC/GB93/051, 930928, EXPIRES:19991215 |
|
| CTFE | Supplementary protection certificate entered into force |
Free format text: SPC/GB93/051, 941216, EXPIRES:19991215 |
|
| PE20 | Patent expired after termination of 20 years |
Effective date: 19941215 |
|
| SPCE | Supplementary protection certificate expired |
Free format text: SPC/GB93/051, 19991215 |